A. Tadić

发表

Gender Differences in Axis I and Axis II Comorbidity in Patients with Borderline Personality Disorder

N. Dahmen, K. Lieb, A. Tadić, 2009, Psychopathology.

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression

R Kohnen, D. Rujescu, H. Stassen, 2005, The Pharmacogenomics Journal.

The MAOA T941G polymorphism and short‐term treatment response to mirtazapine and paroxetine in major depression

D. Rujescu, H. Stassen, N. Dahmen, 2007, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

A monoamine oxidase B gene variant and short-term antidepressant treatment response

Matthias J. Müller, D. Rujescu, H. Stassen, 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: A pilot study

K. Lieb, D. Peetz, A. Tadić, 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression

H. Frieling, S. Bleich, K. Lieb, 2014, Molecular Psychiatry.

Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response.

K. Lieb, A. Tadić, S. Wagner, 2019, Journal of affective disorders.

A meta-analysis of cognitive functions in children and adolescents with major depressive disorder

I. Helmreich, A. Tadić, S. Wagner, 2014, European Child & Adolescent Psychiatry.

The catechol o‐methyltransferase (COMT) val158met polymorphism modulates the association of serious life events (SLE) and impulsive aggression in female patients with borderline personality disorder (BPD)

N. Dahmen, K. Lieb, A. Tadić, 2010, Acta psychiatrica Scandinavica.

Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression

Matthias J. Müller, D. Rujescu, H. Stassen, 2008, Neuropsychiatric disease and treatment.

P-539 - A Meta-analysis of Executive Dysfunctions in Unipolar Major Depressive Disorder (mdd) Without Psychotic Symptoms and Their Changes During Antidepressant Treatment

I. Helmreich, K. Lieb, A. Tadić, 2012, European Psychiatry.

Association analysis of SCN9A gene variants with borderline personality disorder.

N. Dahmen, K. Lieb, A. Tadić, 2008, Journal of psychiatric research.

Association analysis of serotonin receptor 1B (HTR1B) and brain-derived neurotrophic factor gene polymorphisms in borderline personality disorder

N. Dahmen, K. Lieb, A. Tadić, 2009, Journal of Neural Transmission.

Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.

R. Mergl, U. Hegerl, M. Hautzinger, 2010, Journal of affective disorders.

Standardized Rater Training for the Hamilton Depression Rating Scale (HAMD17) and the Inventory of Depressive Symptoms (IDSC30)

I. Helmreich, K. Lieb, A. Tadić, 2010, Psychopathology.

Modulatory role of the brain‐derived neurotrophic factor Val66Met polymorphism on the effects of serious life events on impulsive aggression in borderline personality disorder

N. Dahmen, K. Lieb, A. Tadić, 2010, Genes, brain, and behavior.

The 5-HTTLPR polymorphism modulates the association of serious life events (SLE) and impulsivity in patients with Borderline Personality Disorder.

N. Dahmen, K. Lieb, A. Tadić, 2009, Journal of psychiatric research.

Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression

D. Rujescu, I. Giegling, H. Möller, 2003, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment

O. Tüscher, D. Braus, H. Frieling, 2019, European Archives of Psychiatry and Clinical Neuroscience.

BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response

H. Frieling, S. Bleich, K. Lieb, 2018, Front. Psychiatry.

Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia

Thomas W. Mühleisen, N. Wray, D. Rujescu, 2017, Translational Psychiatry.

Hamilton depression rating subscales to predict antidepressant treatment outcome in the early course of treatment.

A. Szegedi, R. Kohnen, I. Helmreich, 2015, Journal of affective disorders.

Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depression

R. Mergl, U. Hegerl, M. Hautzinger, 2012, European Archives of Psychiatry and Clinical Neuroscience.

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

Husseini Manji, Frank Wiegand, Wayne C. Drevets, 2016, Biological Psychiatry.

Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial

D. Braus, N. Dahmen, M. B. Müller, 2022, Translational Psychiatry.

Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis

N. Dahmen, A. Szegedi, T. Sander, 2006, Psychiatric genetics.

A meta‐analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment

I. Helmreich, K. Lieb, A. Tadić, 2012, Acta psychiatrica Scandinavica.

Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder

D. Braus, K. Lieb, F. Streit, 2022, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depressive Disorders.

K. Lieb, A. Tadić, S. Wagner, 2017, Journal of affective disorders.

Early Improvement and Serum Concentrations of Citalopram to Predict Antidepressant Drug Response of Patients with Major Depression

A. Tadić, S. Wagner, G. Laux, 2013, Pharmacopsychiatry.

Association Between Citalopram Serum Levels and Clinical Improvement of Patients With Major Depression

Matthias J. Müller, A. Tadić, S. Wagner, 2011, Journal of clinical psychopharmacology.

Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years.

K. Lieb, A. Tadić, S. Wagner, 2020, Comprehensive psychiatry.

Association between dopa decarboxylase gene variants and borderline personality disorder

D. Rujescu, I. Giegling, M. Rietschel, 2014, Psychiatry Research.

Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder

D. Braus, K. Lieb, A. Tadić, 2019, BMC Psychiatry.

Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study

K. Lieb, M. Härter, A. Tadić, 2017, European Archives of Psychiatry and Clinical Neuroscience.

Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial

O. Tüscher, D. Braus, N. Dahmen, 2016, European Neuropsychopharmacology.

Association analysis between gene variants of the tyrosine hydroxylase and the serotonin transporter in borderline personality disorder

N. Dahmen, K. Lieb, A. Tadić, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Interaction between gene variants of the serotonin transporter promoter region (5‐HTTLPR) and catechol O‐methyltransferase (COMT) in borderline personality disorder

Norbert Dahmen, Klaus Lieb, Anja Victor, 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Early onset of depression and treatment outcome in patients with major depressive disorder.

M. Müller, K. Lieb, A. Tadić, 2021, Journal of psychiatric research.

The Inventory of Depressive Symptomatology (IDS-C28) is more sensitive to changes in depressive symptomatology than the Hamilton Depression Rating Scale (HAMD17) in patients with mild major, minor or subsyndromal depression

R. Mergl, U. Hegerl, M. Hautzinger, 2011, European Archives of Psychiatry and Clinical Neuroscience.

Lack of modulating effects of the COMT Val(158)Met polymorphism on the association of serious life events (SLE) and impulsivity in patients with Borderline Personality Disorder.

N. Dahmen, K. Lieb, A. Tadić, 2010, Journal of psychiatric research.

A coordinate-based ALE functional MRI meta-analysis of brain activation during verbal fluency tasks in healthy control subjects

Alexandra Sebastian, Oliver Tüscher, Klaus Lieb, 2014, BMC Neuroscience.

Reliability of three alternate forms of the trail making tests a and B.

N. Dahmen, I. Helmreich, K. Lieb, 2011, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression

K. Lieb, D. Peetz, A. Tadić, 2012, Neuropharmacology.

Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder

O. Tüscher, D. Braus, I. Helmreich, 2018, PloS one.

Polymorphisms in the NMDA subunit 2B are not associated with alcohol dependence and alcohol withdrawal–induced seizures and delirium tremens

D. Rujescu, I. Giegling, N. Dahmen, 2005, European Archives of Psychiatry and Clinical Neuroscience.

Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with Major Depressive Disorder - the EMC trial

J. Röschke, D. Braus, N. Dahmen, 2010, Trials.

Pharmakotherapie bei therapieresistenter Depression

K. Lieb, A. Tadić, 2007, Der Nervenarzt.

Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder

D. Braus, N. Dahmen, K. Lieb, 2011, BMC Psychiatry.

The Brain-Derived Neurotrophic Factor (BDNF) Val66Met polymorphism modulates the effects of serious life events on impulsive aggression in patients with Borderline Personality Disorder

N. Dahmen, K. Lieb, A. Tadić, 2009 .

Analysis of genome-wide significant bipolar disorder genes in borderline personality disorder

Thomas W. Mühleisen, D. Rujescu, S. Cichon, 2014, Psychiatric genetics.

R. Mergl, U. Hegerl, M. Hautzinger, 2011, European Archives of Psychiatry and Clinical Neuroscience.

The Serotonin Transporter Promoter Polymorphism (5-HTTLPR) Affects the Relation between Antidepressant Serum Concentrations and Effectiveness in Major Depression

M. Rietschel, J. Röschke, B. Bondy, 2011, Pharmacopsychiatry.

Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder

O. Tüscher, D. Braus, S. Kayser, 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial

S. Witt, F. Streit, S. Sordon, 2022, Translational Psychiatry.

Efficacy and Safety of Intravenous Esketamine in Patients with Treatment-resistant Depression: A Double-blind, Double-randomization, Placebo-controlled Phase 2a Study

W. Drevets, P. Sienaert, H. Manji, 2013 .

Association analysis between gene variants of the tyrosine hydroxylase and the serotonin transporter in borderline personality disorder

N. Dahmen, K. Lieb, A. Tadić, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Variable number of tandem repeat polymorphisms of the arginine vasopressin receptor 1A gene and impulsive aggression in patients with borderline personality disorder.

N. Dahmen, B. Leuenberger, A. Mobascher, 2012, Psychiatric genetics.

Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: Systematic review and meta-analysis.

Jan Engelmann, Klaus Lieb, A. Tadić, 2017, Journal of psychiatric research.

Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment

H. Frieling, A. Tadić, 2013, International review of psychiatry.

Early Improvement and Serum Concentrations of Citalopram to Predict Antidepressant Drug Response of Patients with Major Depression

A. Tadić, S. Wagner, G. Laux, 2013, Pharmacopsychiatry.

The Amount of Mitochondrial DNA in Blood Reflects the Course of a Depressive Episode

Frederick W. Vonberg, R. Mott, A. Bhomra, 2016, Biological Psychiatry.

Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder

M. Müller, K. Lieb, A. Tadić, 2020, Journal of clinical psychopharmacology.